RNA Inhibitor Is Shown Safe and Effective in Reduc : vimarsa

A small interfering RNA (siRNA) investigational therapy that inhibits a gene involved in lipoprotein metabolism has been shown in a clinical trial led by M

Related Keywords

France , New York , United States , Robert Rosenson , Ilana Nikravesh , Arrowhead Pharmaceuticals Inc , Metabolism For The Mount Sinai Health System , Drug Administration , Zodasiran Arrowhead Pharmaceuticals , European Atherosclerosis Society Congress On , Icahn School Of Medicine At Mount Sinai , Mount Sinai Press Office , Wide Range , Triglyceride Levels , Mount Sinai Led Clinical Trial , Mount Sinai , European Atherosclerosis Society Congress , New England Journal , Arrowhead Pharmaceuticals , Icahn School , Mount Sinai Health ,